Scientists at the University of Oxford and the University of Southampton in the UK have found that hormone replacement therapy can reduce mortality from viral diseases within six months of the recorded diagnosis of Covid-19. The results of the study were published in the journal Family Practice. While conducting the study, researchers examined the relationship between hormone replacement therapy or combined oral contraceptive use and the risk of death in women with COVID-19.
Scientists have tested a combination of oral contraceptives, which contain estrogen, because some recent observations show that women who take oral contraceptives have a lower risk of developing COVID-19. The team used an earlier team with medical records from the Oxford-Royal College of General Practitioners Research and Surveillance Centre’s primary care database. In addition, the team identified a team of 1,863,478 women over the age of 18 from 465 general practices in England.
According to scientists, hormone replacement therapy Covid-19 was associated with a 22 percent reduction in mortality. This suggests that estrogen may have a protective effect against the exacerbation of COVID-19.
“This study supports the theory that estrogen may provide some protection against severe COVID-19. We hope this study can reassure patients and physicians that there is no indication that the epidemic will stop hormone replacement therapy, “said Christopher Wilcox, one of the authors of the study.
Researchers have also found that although men and women are equally susceptible to the SARS-CoV-2 virus, men are more prone to more serious infections. Meanwhile, previous studies have also shown that women have faster and greater immunity to viral infections.
In addition, researchers have observed similar data in previous epidemics, including outbreaks of severe acute respiratory syndrome corona virus (SARS-CoV) and Middle Eastern respiratory syndrome corona virus (MERS-CoV).
“The reason for this gender difference is uncertain. Limited recent observational data suggest that estrogen may reduce the severity of COVID-19 disease, ”the study authors noted.